These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9536015)

  • 1. Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to purified integrin alphaIIbbeta3: evidence for a common binding site for cyclic arginyl-glycinyl-aspartic acid peptides and nonpeptides.
    Wong A; Hwang SM; Johanson K; Samanen J; Bennett D; Landvatter SW; Chen W; Heys JR; Ali FE; Ku TW; Bondinell W; Nichols AJ; Powers DA; Stadel JM
    J Pharmacol Exp Ther; 1998 Apr; 285(1):228-35. PubMed ID: 9536015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
    Wong A; Hwang SM; McDevitt P; McNulty D; Stadel JM; Johanson K
    Mol Pharmacol; 1996 Sep; 50(3):529-37. PubMed ID: 8794891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential recognition of snake venom proteins expressing specific Arg-Gly-Asp (RGD) sequence motifs by wild-type and variant integrin alphaIIbbeta3: further evidence for distinct sites of RGD ligand recognition exhibiting negative allostery.
    Rahman S; Flynn G; Aitken A; Patel Y; Hussain F; Lu X; Loftus JC; French D; Wijelath E; Strand K; Savidge GF
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):701-9. PubMed ID: 10642531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Basis for the Binding of RGD- and AGDV-Peptides to the Platelet Integrin αIIbβ3.
    Kononova O; Litvinov RI; Blokhin DS; Klochkov VV; Weisel JW; Bennett JS; Barsegov V
    Biochemistry; 2017 Apr; 56(13):1932-1942. PubMed ID: 28277676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AlphaIIbbeta3 and its antagonism at the new millennium.
    Plow EF; Cierniewski CS; Xiao Z; Haas TA; Byzova TV
    Thromb Haemost; 2001 Jul; 86(1):34-40. PubMed ID: 11487023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
    Samanen J; Ali F; Romoff T; Calvo R; Sorenson E; Vasko J; Storer B; Berry D; Bennett D; Strohsacker M
    J Med Chem; 1991 Oct; 34(10):3114-25. PubMed ID: 1920361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disintegrin echistatin stabilizes integrin alphaIIbbeta3's open conformation and promotes its oligomerization.
    Hantgan RR; Stahle MC; Connor JH; Lyles DS; Horita DA; Rocco M; Nagaswami C; Weisel JW; McLane MA
    J Mol Biol; 2004 Oct; 342(5):1625-36. PubMed ID: 15364586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic: distinct binding profile for Roxifiban.
    Mousa SA; Bozarth JM; Naik UP; Slee A
    Br J Pharmacol; 2001 Jun; 133(3):331-6. PubMed ID: 11375248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for distinctive recognition of fibrinogen gammaC peptide by the platelet integrin alphaIIbbeta3.
    Springer TA; Zhu J; Xiao T
    J Cell Biol; 2008 Aug; 182(4):791-800. PubMed ID: 18710925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positional importance of Pro53 adjacent to the Arg49-Gly50-Asp51 sequence of rhodostomin in binding to integrin alphaIIbbeta3.
    Chang CP; Chang JC; Chang HH; Tsai WJ; Lo SJ
    Biochem J; 2001 Jul; 357(Pt 1):57-64. PubMed ID: 11415436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide ligands can bind to distinct sites in integrin alphaIIbbeta3 and elicit different functional responses.
    Cierniewski CS; Byzova T; Papierak M; Haas TA; Niewiarowska J; Zhang L; Cieslak M; Plow EF
    J Biol Chem; 1999 Jun; 274(24):16923-32. PubMed ID: 10358039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Platelet Integrin αIIbβ3 Differentially Interacts with Fibrin Versus Fibrinogen.
    Litvinov RI; Farrell DH; Weisel JW; Bennett JS
    J Biol Chem; 2016 Apr; 291(15):7858-67. PubMed ID: 26867579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro pharmacological profile of SK&F 106760, a novel GPIIB/IIIA antagonist.
    Nichols AJ; Vasko JA; Valocik RE; Kopaciewicz LJ; Storer BL; Ali FE; Romoff T; Calvo R; Samanen JM
    Thromb Res; 1994 Jul; 75(2):143-56. PubMed ID: 7974388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
    Wittig K; Rothe G; Schmitz G
    Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+-dependent binding of a synthetic Arg-Gly-Asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb-IIIa complex.
    Steiner B; Cousot D; Trzeciak A; Gillessen D; Hadváry P
    J Biol Chem; 1989 Aug; 264(22):13102-8. PubMed ID: 2753902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of synthetic peptides corresponding to residues 313-332 of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3.
    Mitsios JV; Tambaki AP; Abatzis M; Biris N; Sakarellos-Daitsiotis M; Sakarellos C; Soteriadou K; Goudevenos J; Elisaf M; Tsoukatos D; Tsikaris V; Tselepis AD
    Eur J Biochem; 2004 Feb; 271(4):855-62. PubMed ID: 14764102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.